Nemaura Medical Alpha and Beta Analysis
| NMRDDelisted Stock | USD 0.93 0.01 1.06% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Nemaura Medical. It also helps investors analyze the systematic and unsystematic risks associated with investing in Nemaura Medical over a specified time horizon. Remember, high Nemaura Medical's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Nemaura Medical's market risk premium analysis include:
Beta (0.09) | Alpha 0.35 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Nemaura |
Nemaura Medical Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Nemaura Medical market risk premium is the additional return an investor will receive from holding Nemaura Medical long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Nemaura Medical. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Nemaura Medical's performance over market.| α | 0.35 | β | -0.09 |
Nemaura Medical Fundamentals Vs Peers
Comparing Nemaura Medical's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Nemaura Medical's direct or indirect competition across all of the common fundamentals between Nemaura Medical and the related equities. This way, we can detect undervalued stocks with similar characteristics as Nemaura Medical or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Nemaura Medical's fundamental indicators could also be used in its relative valuation, which is a method of valuing Nemaura Medical by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Nemaura Medical to competition |
| Fundamentals | Nemaura Medical | Peer Average |
| Return On Equity | -7.24 | -0.31 |
| Return On Asset | -0.49 | -0.14 |
| Current Valuation | 22.58 M | 16.62 B |
| Shares Outstanding | 28.9 M | 571.82 M |
| Shares Owned By Insiders | 48.30 % | 10.09 % |
| Shares Owned By Institutions | 7.70 % | 39.21 % |
| Number Of Shares Shorted | 52.57 K | 4.71 M |
Nemaura Medical Opportunities
Nemaura Medical Return and Market Media
The Stock did not receive any noticable media coverage during the period. Price Growth (%) |
| Timeline |
About Nemaura Medical Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Nemaura or other pink sheets. Alpha measures the amount that position in Nemaura Medical has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Nemaura Medical Upcoming Company Events
As portrayed in its financial statements, the presentation of Nemaura Medical's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Nemaura Medical's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Nemaura Medical's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Nemaura Medical. Please utilize our Beneish M Score to check the likelihood of Nemaura Medical's management manipulating its earnings.
| 23rd of February 2024 Upcoming Quarterly Report | View | |
| 11th of July 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 11th of July 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of March 2023 Last Financial Announcement | View |
Build Portfolio with Nemaura Medical
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Consideration for investing in Nemaura Pink Sheet
If you are still planning to invest in Nemaura Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nemaura Medical's history and understand the potential risks before investing.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |